New York Times Top Stories: Post

New York Times Top Stories

F.D.A. Limits Use of Antibody Treatments That Are Weaker Against Omicron

Regeneron and Eli Lilly medications were effective against the Delta variants, but less so with Omicron. Here’s the latest pandemic news.

Continue Reading…